Literature DB >> 18083694

Reversible liver toxicity with adjuvant trastuzumab for localized breast cancer.

A Muñoz, S Carrera, J Ferreiro, A Ruiz de Lobera, J M Mañé, G López-Vivanco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18083694     DOI： 10.1093/annonc/mdm515

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Trastuzumab-induced hepatotoxicity: a case report.

Authors:  Darko Vucicevic; Elizabeth J Carey; Nina J Karlin
Journal:  Breast Care (Basel)       Date:  2013-05       Impact factor: 2.860

2.  Hepatotoxicity induced by trastuzumab used for breast cancer adjuvant therapy: a case report.

Authors:  Kazuo Ishizuna; Jun Ninomiya; Toshihisa Ogawa; Eiichi Tsuji
Journal:  J Med Case Rep       Date:  2014-12-10

3.  A phase I dose-escalation study of a biosimilar trastuzumab in Chinese metastasis breast cancer patients.

Authors:  Xinna Zhou; Jing Yu; Wenmiao Wang; Guohong Song; Xiaoli Wang; Jun Ren; Lijun Di; Xinghe Wang
Journal:  Springerplus       Date:  2015-12-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.